申请人:SHIONOGI & CO., LTD.
公开号:EP0552060A1
公开(公告)日:1993-07-21
A novel imidazole derivatives of formula I:
wherein R¹ is hydrogen, alkyl, halogen, or optionally substituted aryl; R² is alkyl, optionally substituted aryl optionally substituted aralkyl, or optionally substituted hetero ring group; R³ is hydrogen, alkyl, optionally substituted aryl, optionally substituted aralkyl, or optionally substituted hydroxyalkyl; R⁴ is hydrogen, alkyl, halogen, acyl, optionally substituted hydroxyalkyl, optionally esterified or amidated carboxyl group, hydroxy group, aryl or arylthio; X is S, SO, SO₂, CH₂, or Se; n is an integer of 1 to 3, or a pharmaceutically acceptable salt thereof, said derivative having anti-HIV activity and being useful for the treatment of HIV infections.
式 I 的新型咪唑衍生物:
其中 R¹ 是氢、烷基、卤素或任选取代的芳基;R² 是烷基、任选取代的芳基、任选取代的芳烷基或任选取代的杂环基团;R³ 是氢、烷基、任选取代的芳基、任选取代的芳烷基或任选取代的羟烷基;R⁴是氢、烷基、卤素、酰基、任选取代的羟烷基、任选酯化或酰胺化的羧基、羟基、芳基或芳硫基;X 是 S、SO、SO₂、CH₂ 或 Se;n 是 1 至 3 的整数,或其药学上可接受的盐,所述衍生物具有抗 HIV 活性,可用于治疗 HIV 感染。